Efficacy of carboplatin with an MEP (mitoxantrone, etoposide and prednisone) regimen for relapsed and CHOP-resistant diffuse large B-cell lymphomas
To access this article, please choose from the options below
PII: S0145-2126(01)00114-X
© 2002 Elsevier Science Ltd. All rights reserved.
